NCT03405402View on ClinicalTrials.gov

Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization

NACompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

February 13, 2018

Primary Completion Date

August 3, 2020

Study Completion Date

August 3, 2020

Conditions
Sickle Cell Disease
Interventions
PROCEDURE

Blood sampling

Extra blood sampling at the time of a blood transfusion in order to perform the laboratory analysis

Trial Locations (2)

1020

CHU Brugmann, Brussels

HUDERF, Brussels

All Listed Sponsors
lead

Hanane EL KENZ

OTHER

NCT03405402 - Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization | Biotech Hunter | Biotech Hunter